Lymphovascular and perineural invasion in the parametria: A prognostic factor for early-stage cervical cancer

被引:127
作者
Memarzadeh, S
Natarajan, S
Dandade, DP
Ostrzega, N
Saber, PA
Busuttil, A
Lentz, SE
Berek, JS
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol,Ctr Hlth Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[3] Kaiser Permanente, Los Angeles Med Ctr, Dept Pathol, Los Angeles, CA USA
[4] Kaiser Permanente, Los Angeles Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA USA
关键词
D O I
10.1016/S0029-7844(03)00569-6
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
OBJECTIVE: To estimate the impact of parametrial lymphovascular and perineural involvement on nodal metastasis and failure pattern of women with early-stage, surgically treated cervical cancer. METHODS: Clinical records and pathologic slides of 93 patients with early-stage cervical cancer (2 IA(2), 52 IB1,31 IB2, and 8 IIA) treated with radical hysterectomy and pelvic lymphadenectomy with or without paraaortic lymphadenectomy were reviewed. The study group comprised 80 patients with squamous cell carcinoma and 13 patients with adenocarcinoma, of the cervix. Median follow-up time was 33 months. The association among the various histopathologic predictors of outcome was determined with chi(2) analysis. The influence of the predictors on outcome was examined with log rank survival methods and the Cox regression model. RESULTS: The presence of parametrial lymphovascular space invasion is a predictor of disease in the pelvic (P < .001) and paraaortic (P < .05) lymphatics independently large tumor size (greater than 4 cm), parametrial perineural invasion, cervical lymphovascular space invasion, and tumor depth (greater than two thirds) were found to be simultaneous predictors of recurrence on multivariate analysis (P < .05). Using these four binary predictor variables, we have computed a model-based relative risk. Based on this model, the presence of perineural invasion in the parametria more than doubles the risk of recurrence in the cohort of patients with large (greater than 4 cm) tumors (P < .05). In a subset analysis of patients with negative nodal disease, parametrial perineural invasion and tumor size were independent predictors of poor outcome (P < .05). CONCLUSION: Presence of parametrial lymphovascular space invasion correlates significantly with the risk of nodal metastasis in women with early-stage cervical cancer. Parametrial perineural invasion is an independent poor prognostic factor. Histopathologic findings within the parametria are a valuable independent predictor of recurrence and thus may influence the selection of patients for adjuvant treatment. (C) 2003 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:612 / 619
页数:8
相关论文
共 30 条
[1]
[Anonymous], 1905, BEITR PATHOL
[2]
ASKANAZY M, 1912, KLIN WCHNSCHR, V29, P2161
[3]
BEREK JS, 2000, PRACTICAL GYNECOLOGI, P354
[4]
THE SIGNIFICANCE OF MICROSCOPIC INVOLVEMENT OF THE PARAMETRIUM AND OR PELVIC LYMPH-NODES IN CERVICAL-CANCER STAGE-IB AND STAGE-IIA [J].
BLEKER, OP ;
KETTING, BW ;
VANWAYJENEECEN, B ;
KLOOSTERMAN, GJ .
GYNECOLOGIC ONCOLOGY, 1983, 16 (01) :56-62
[5]
Brunet G., 1905, Z GEBURTSH GYNAKOL, V56, P1
[6]
PROGNOSTIC FACTORS AND OPERATIVE TREATMENT OF STAGE-IB TO STAGE-IIB CERVICAL-CANCER [J].
BURGHARDT, E ;
PICKEL, H ;
HAAS, J ;
LAHOUSEN, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (04) :988-996
[7]
THE SIGNIFICANCE OF THE PARAMETRIUM IN THE OPERATIVE TREATMENT OF CERVICAL-CANCER [J].
BURGHARDT, E ;
HAAS, J ;
GIRARDI, F .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1988, 2 (04) :879-888
[8]
Clark J.G., 1895, Johns Hopkins Hosp. Bull, V6, P120
[9]
PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, B ;
ZAINO, R ;
SEVIN, BU ;
CREASMAN, WT ;
MAJOR, F .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :352-357
[10]
Grisaru D, 2001, CANCER, V92, P2999, DOI 10.1002/1097-0142(20011215)92:12<2999::AID-CNCR10145>3.0.CO